Single-Center Experience With Lutonix Drug-Coated Balloons in Infrapopliteal Arteries

Conclusion: From this single-center experience, the Lutonix DCB shows therapeutic promise in a disease state where new treatment options are needed.

Source: Journal of Endovascular Therapy - May 10, 2016 Category: Surgery Authors: Steiner, S., Schmidt, A., Bausback, Y., Bräunlich, S., Ulrich, M., Banning-Eichenseer, U., Scheinert, D. Tags: Lower Limb Interventions Source Type: research